Actively Recruiting
Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
Led by Helsinki University Central Hospital · Updated on 2023-09-22
100
Participants Needed
1
Research Sites
334 weeks
Total Duration
On this page
Sponsors
H
Helsinki University Central Hospital
Lead Sponsor
U
University of Helsinki
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.
CONDITIONS
Official Title
Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female subjects aged 18 years
- History of recurrent UTI with at least two episodes over the past 6 months or at least three episodes over the past year
- Most recent UTI episode within the past three months
- Written informed consent
You will not qualify if you...
- Suspected non-compliance
- Diagnosis of a gastrointestinal disease
- Pregnancy
- Immunosuppression
- Any kind of permanent urinary catheter or intermittent urinary catheterization
- Any other criteria deemed by the investigator to compromise participation, well-being, or study outcome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Meilahti Vaccine Research Center, Helsinki University Central Hospital
Helsinki, Finland, 00290
Actively Recruiting
Research Team
S
Sari Pakkanen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here